The FDA is considering authorizations for Pfizer’s paxlovid and Merck & Co.’s molnupiravir, the first two oral COVID-19 antivirals.
Discover the world’s best science and medicine | Nature.com
Discover the world’s best science and medicine | Nature.com
Discover the world’s best science and medicine | Nature.com
Discover the world’s best science and medicine | Nature.com
Discover the world’s best science and medicine | Nature.com
Discover the world’s best science and medicine | Nature.com
Despite a regulatory setback for Provention Bio’s diabetes prevention candidate teplizumab, hopes remain high for T cell-regulating therapies in autoimmune indications including multiple sclerosis, systemic lupus erythematosus and coeliac disease.
The authors of this study designed a novel therapeutic class of antimicrobials in which they optimized drug binding and permeation of the drug through bacterial membrane transporters simultaneously.
Li, Xiao and colleagues show that antihistamines might increase the efficacy of immune checkpoint blockade.
Discover the world’s best science and medicine | Nature.com
Enhanced levels of the pro-inflammatory lipid prostaglandin E 2 (PGE 2 ) in the ageing immune system cause metabolic changes in macrophages and microglia that are associated with chronic inflammation and impaired cognition. Inhibition of the PGE 2 receptor was shown to reduce brain inflammation and restore memory in mice.
Discover the world’s best science and medicine | Nature.com
Exosomes — small extracellular vesicles that are shed by cells — have long offered promise as drug delivery systems for small molecules, DNA, RNA and other biologic payloads. The first of these are now in the clinic. Exosomes — small extracellular vesicles that are shed by cells — have long offered promise as drug delivery systems for small molecules, DNA, RNA and other biologic payloads. The first of these are now in the clinic.
Discover the world’s best science and medicine | Nature.com
J&J's phase II trial of an immunomodulator for depression could inform the development of stratified medicine in psychiatry. J&J's phase II trial of an immunomodulator for depression could inform the development of stratified medicine in psychiatry.
Discover the world’s best science and medicine | Nature.com